{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:48:28Z","timestamp":1791143308137,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T00:00:00Z","timestamp":1399852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Military Vaccine Agency (MILVAX), Military Infectious Diseases Research Program (MIDRP), contract #W911QY-08-D-022","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T13:01:08Z","timestamp":1400072468000},"page":"3805-3809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2848-4230","authenticated-orcid":false,"given":"Manisha","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Romero-Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Plikaytis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Carlone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Faix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (2)","key":"10.1016\/j.vaccine.2014.05.001_bib0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","article-title":"Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease","volume":"50","author":"Cohn","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.05.001_bib0010","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1086\/520303","article-title":"Complications and sequelae of meningococcal disease in Quebec, Canada, 1990\u20131994","volume":"26","author":"Erickson","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2014.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/167.6.1320","article-title":"Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis","volume":"167","author":"Wang","year":"1993","journal-title":"J Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2014.05.001_bib0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11908-011-0195-7","article-title":"Meningococcal disease: shifting epidemiology and genetic mechanisms that may contribute to serogroup C virulence","volume":"13","author":"Macneil","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2014.05.001_bib0025","first-page":"275","article-title":"Meningococcal infections. 1. Prevalence of serogroups causing disease in US Army personnel in 1964\u201370","volume":"45","author":"Artenstein","year":"1971","journal-title":"Bull World Health Organ"},{"issue":"May (RR-7)","key":"10.1016\/j.vaccine.2014.05.001_bib0030","first-page":"1","article-title":"Prevention and control of meningococcal disease recommendations of the advisory committee on immunization practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2014.05.001_bib0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.6.11.12849","article-title":"Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo(R)) or Menactra(R) among healthy adolescents","volume":"6","author":"Gill","year":"2010","journal-title":"Hum Vaccin"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.05.001_bib0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2014.05.001_bib0045","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3201\/eid1809.120257","article-title":"Trends in meningococcal disease in the United States military, 1971\u20132010","volume":"18","author":"Broderick","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2014.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.2105\/AJPH.92.12.1900","article-title":"The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance","volume":"92","author":"Rubertone","year":"2002","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2014.05.001_bib0055","series-title":"Armed Forces Health Surveillance Center, Fiscal Year 2011 Report","year":"2011"},{"key":"10.1016\/j.vaccine.2014.05.001_bib0060","first-page":"289","article-title":"C serum bactericidal assays","volume":"66","author":"Borrow","year":"2001","journal-title":"Methods Mol Med"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2014.05.001_bib0065","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2014.05.001_bib0070","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2014.05.001_bib0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2014.05.001_bib0080","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2014.05.001_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992","volume":"2","author":"Holder","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"November (7941)","key":"10.1016\/j.vaccine.2014.05.001_bib0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(75)92125-X","article-title":"Effect of group-A meningococcal vaccine in army recruits in Finland","volume":"2","author":"Makela","year":"1975","journal-title":"Lancet"},{"issue":"September (13)","key":"10.1016\/j.vaccine.2014.05.001_bib0095","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.05.001_bib0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/169.4.847","article-title":"Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel","volume":"169","author":"Zangwill","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.001_bib0105","article-title":"Antibody persistence and response to a booster dose of a quadrivalent conjugate vaccine for meningococcal disease in adolescents","author":"Jacobson","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2014.05.001_bib0110","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/509619","article-title":"Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom","volume":"194","author":"Auckland","year":"2006","journal-title":"J Infect Dis"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2014.05.001_bib0115","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"March (RR-2)","key":"10.1016\/j.vaccine.2014.05.001_bib0120","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14006562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T11:31:18Z","timestamp":1597836678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14006562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":24,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14006562"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}